These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 22122747)
1. Modulation of gene expression in ovarian cancer by active and repressive histone marks. Bapat SA Epigenomics; 2010 Feb; 2(1):39-51. PubMed ID: 22122747 [TBL] [Abstract][Full Text] [Related]
2. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic control of ovarian function: the emerging role of histone modifications. LaVoie HA Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Vaissière T; Sawan C; Herceg Z Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of CIITA expression in human T-cells. van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896 [TBL] [Abstract][Full Text] [Related]
7. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589 [TBL] [Abstract][Full Text] [Related]
8. Histone onco-modifications. Füllgrabe J; Kavanagh E; Joseph B Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126 [TBL] [Abstract][Full Text] [Related]
9. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines. Yatouji S; El-Khoury V; Trentesaux C; Trussardi-Regnier A; Benabid R; Bontems F; Dufer J Int J Oncol; 2007 Apr; 30(4):1003-9. PubMed ID: 17332941 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic analysis in the search for tumor suppressor genes. Han ZG Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966 [No Abstract] [Full Text] [Related]
15. Targeting DNA methylation in cancer. Szyf M Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
17. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells. Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283 [TBL] [Abstract][Full Text] [Related]
18. DNA methylation and histone modification regulate silencing of OPG during tumor progression. Lu TY; Kao CF; Lin CT; Huang DY; Chiu CY; Huang YS; Wu HC J Cell Biochem; 2009 Sep; 108(1):315-25. PubMed ID: 19565568 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of airway inflammation. Adcock IM; Tsaprouni L; Bhavsar P; Ito K Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468 [TBL] [Abstract][Full Text] [Related]
20. Epigenetics in ovarian cancer: premise, properties, and perspectives. Yang Q; Yang Y; Zhou N; Tang K; Lau WB; Lau B; Wang W; Xu L; Yang Z; Huang S; Wang X; Yi T; Zhao X; Wei Y; Wang H; Zhao L; Zhou S Mol Cancer; 2018 Jul; 17(1):109. PubMed ID: 30064416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]